title: [Triple therapy with direct acting antiviral agent, peginterferon and ribavirin for chronic hepatitis C].
authors.affiliation: Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Japan. nizumi@musashino.jrc.or.jp
authors.forename: Namiki
authors.initials: N
authors.lastname: Izumi
authors.forename: Masayuki
authors.initials: M
authors.lastname: Kurosaki
authors.forename: Shoko
authors.initials: S
authors.lastname: Suzuki
authors.forename: Nobuharu
authors.initials: N
authors.lastname: Tamaki
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D016899:Interferon-beta / Q000008:administration & dosage*; D009842:Oligopeptides / Q000008:administration & dosage*; D011092:Polyethylene Glycols / Q000008:administration & dosage*; D011994:Recombinant Proteins / Q000008:administration & dosage; D012254:Ribavirin / Q000008:administration & dosage*
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D009842:Oligopeptides; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C486464:telaprevir; D016899:Interferon-beta; C417083:peginterferon alfa-2b; C428112:peginterferon beta-1a